Group @ received fibrin glue manufactured by the Blood and Tissue Bank of Catalonia , Group @ received Tissucol ( fibrinogen and thrombin ) , Group @ received intravenous tranexamic acid , and Group @ ( control ) had no treatment other than routine hemostasis .